MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-02-0031279
Eveksia Pharma Private Limited
Eveksia Pharma Private Limited - healthcare in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2023
₹1.02 Cr
▲ 129% YoY
Net profit · FY 2023
₹2.09 Lakh
Net margin 2.1%
EBITDA · FY 2023
₹3.84 Lakh
EBITDA margin 3.8%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
9 yrs
Est. 2017
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered
About Eveksia Pharma Private Limited
Data last updated:
Eveksia Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the medical equipment retail and distribution segment of the healthcare sector. It was incorporated on 07 August 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U33110DL2017PTC321810. Its GSTIN is 07AAECE7441G1ZP (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Raghubar Bharti and Chandan Singh.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at B – 49 First Floor Dsidc Complex Kalyanpuri, New Delhi, Delhi, India – 110091.
As per the financials filed for FY 2023, the company reported a revenue of ₹1.02 Cr, a growth of 129% compared to the previous year. For the same year it recorded a net profit of ₹2.09 Lakh (net margin 2.1%) and EBITDA of ₹3.84 Lakh (EBITDA margin 3.8%). Revenue has grown at a compounded annual rate (CAGR) of 83% over three years and 253% over five years.
Court records list 8 cases involving the company, including 8 filed against it; 7 cases are pending.
Eveksia Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-02-0031279). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U33110DL2017PTC321810
Registration Number 321810
Incorporation Date 07 August 2017
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2023
Date of Balance Sheet 31 March 2023
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-02-0031279
Recognitions & Rankings of Eveksia Pharma
Contact details
Eveksia Pharma Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressB – 49 First Floor Dsidc Complex Kalyanpuri, New Delhi, Delhi, India – 110091
- IndustryHealthcare, Medical Equipment Retail & Distribution
To see the full contact details of Eveksia Pharma Private Limited, buy the company report.
Comprehensive company report
Eveksia Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Eveksia Pharma is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Eveksia Pharma Private Limited, buy the company report.
Financials of Eveksia Pharma Private Limited
FY 2023 filings availableEveksia Pharma Private Limited reported revenue of ₹1.02 Cr (up 129% YoY) for FY 2023.
Revenue · FY 2023
₹1.02 Cr ▲ 129%
Net profit · FY 2023
₹2.09 Lakh margin 2.1%
EBITDA · FY 2023
₹3.84 Lakh margin 3.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 129%
3 years · compounded
▲ 83%
5 years · compounded
▲ 253%
EBITDA CAGR growth
1 year
▲ 360%
3 years · compounded
▲ 116%
5 years · compounded
▲ 83%
Revenue has grown at a compounded annual rate (CAGR) of 253% over five years, including 129% growth in the latest year. EBITDA rose 360% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹1.02 Cr | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.84 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.09 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.8% | ||||
| Net Profit Margin | 2.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Eveksia Pharma Private Limited, buy the company report.
Board of directors of Eveksia Pharma Private Limited
Eveksia Pharma has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Raghubar Bharti Also directs: Unrogya Pharmacy Private Limited | Director | 07 Aug 2017 | 9 Years 2 Months | Current |
| Chandan Singh Also directs: Manlive Pharma Private Limited | Director | 24 Feb 2020 | 6 Years 8 Months | Current |
| Mukesh Bharti | Director | 07 Aug 2017 | 9 Years 2 Months | Current |
Auditor
Eveksia Pharma Private Limited is audited by S GOYAL & COMPANY for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S GOYAL & COMPANY | FY 2023 | 525832 |
Shareholding
The shareholding of Eveksia Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Eveksia Pharma Private Limited, buy the company report.
Legal cases
Eveksia Pharma Private Limited has 8 court cases on record: 8 filed against it. 7 cases are pending and 1 is disposed.
Total cases
8
Filed against the company
8
Pending
7
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 8 | 8 | 7 |
Cases on record (5 of 8)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Gautam Buddha Nagar, Uttar Pradesh | Criminal case | Filed against the company by Kisetsu Saison Finance India Private Limited | Pending |
| District court, New Delhi, Delhi | Cheque dishonour complaint | Filed against the company by Equentia Financial Service Pvt Ltd | Pending |
| District court, South West, Delhi | Cheque dishonour complaint | Filed against the company by Idfc First Bank Ltd | Pending |
| District court, Yamunanagar, Haryana | Civil suit | Filed against the company by Indorama Health Care Pvt Ltd Th Director Anshul Jindal | Pending |
| District court, South West, Delhi | Cheque dishonour complaint | Filed against the company by Hero Fincorp Ltd | Disposed |
To see the full case history of Eveksia Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Eveksia Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Eveksia Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAECE7441G1ZP | Delhi | Active | 08 Dec 2017 |
To see the full GST registrations and return filing status of Eveksia Pharma Private Limited, buy the company report.
Recent activity
Eveksia Pharma Private Limited has 3 board changes on record since 2017: 3 appointments. The latest: Chandan Singh was appointed as Director on 24 Feb 2020.
AGM
Eveksia Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Filing
Eveksia Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi I.
Appointed
Chandan Singh was appointed as Director.
Appointed
Mukesh Bharti was appointed as Director.
Appointed
Raghubar Bharti was appointed as Director.
Incorporation
07 Aug 2017
Eveksia Pharma Private Limited was registered on 07 Aug 2017 with Roc Delhi I & aged 9 years 2 months as per MCA records.
Frequently asked questions
Eveksia Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in medical equipment retail and distribution, within the healthcare industry. It was incorporated on 07 August 2017 (9+ years old) and is registered under CIN U33110DL2017PTC321810.
Eveksia Pharma has 3 current directors:
- Raghubar Bharti - Director
- Chandan Singh - Director
- Mukesh Bharti - Director
The latest financial statements of Eveksia Pharma on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Eveksia Pharma is 07AAECE7441G1ZP, registered in Delhi.
The CIN (Corporate Identification Number) of Eveksia Pharma is U33110DL2017PTC321810. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Eveksia Pharma has 8 court cases on record: 8 filed against it. 7 are pending.
Eveksia Pharma was incorporated on 07 August 2017, making it 9+ years old. It is registered with the Registrar of Companies, Delhi.
Chandan Singh was appointed as Director on 24 Feb 2020. Mukesh Bharti was appointed as Director on 07 Aug 2017. Raghubar Bharti was appointed as Director on 07 Aug 2017.
Yes, Eveksia Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-02-0031279).
The registered office of Eveksia Pharma is at B – 49 First Floor Dsidc Complex Kalyanpuri, New Delhi, Delhi, India – 110091.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages